As per MRFR analysis, the US Surgical Stents Market Size was estimated at 2.83 (USD Billion) in 2023. The US Surgical Stents Market Industry is expected to grow from 3.5(USD Billion) in 2024 to 8.5 (USD Billion) by 2035. The US Surgical Stents Market CAGR (growth rate) is expected to be around 8.401% during the forecast period (2025 - 2035).
The US Surgical Stents Market is witnessing several important trends shaping its landscape. One of the key market drivers is the increasing prevalence of chronic diseases, such as cardiovascular and urological conditions, leading to a higher demand for surgical stenting procedures. According to the Centers for Disease Control and Prevention (CDC), heart disease is a leading cause of death in the US, which drives the need for innovative stent technologies that cater to a growing patient population.
Moreover, advancements in stent designs, materials, and coatings are being explored, enhancing patient outcomes and expanding their applications in minimally invasive surgeries. Opportunities within the US market are also burgeoning, particularly around the aging population that is more susceptible to health issues requiring stenting. Innovative technologies, such as bioresorbable stents and drug-eluting stents, present significant opportunities for manufacturers to cater to evolving medical needs.
The implementation of telehealth and remote monitoring solutions is likely to further augment the market by providing better patient management and follow-up care. Recent trends show a shift towards patient-centric approaches, with an emphasis on personalized medicine and tailored treatment plans based on individual patient profiles. This customization is being propelled by technological advances in medical imaging and data analytics, helping healthcare professionals make better decisions regarding stent applications.
Additionally, regulatory bodies are actively involved in ensuring the safety and efficacy of stents, leading to a more structured approval process for new devices, which supports the overall growth of the market in the US. Overall, these trends underscore the dynamic nature of the US Surgical Stents Market, with significant implications for stakeholders involved in the healthcare sector.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US is witnessing a growing incidence of cardiovascular diseases, which significantly drives the US Surgical Stents Market Industry. According to the American Heart Association, approximately 697,000 deaths were reported in 2020 due to heart disease, making it the leading cause of death in the country. Furthermore, the Centers for Disease Control and Prevention reports that one in every five deaths in the US is attributed to cardiovascular conditions.
This increasing prevalence leads to a higher demand for surgical interventions, including the implantation of stents, thereby facilitating market growth. Companies like Boston Scientific and Medtronic are innovating with advanced stent technologies to address this escalating health crisis, which underscores the vital role that surgical stents play in the treatment of heart disease in the United States.
Innovations in stent technologies are significantly influencing the US Surgical Stents Market Industry. The introduction of drug-eluting stents and bioresorbable stents has revolutionized how cardiovascular diseases are treated. According to industry reports, the adoption of drug-eluting stents reduces the risk of restenosis by up to 50% compared to bare-metal stents. Companies such as Abbott and Terumo have invested substantially in Research and Development to refine these technologies.
The Food and Drug Administration emphasizes the importance of such advancements, paving the way for more effective and safer treatment options for patients across the United States.
The aging population in the US serves as a significant market driver for the US Surgical Stents Market Industry. By 2030, it is projected that one in five US residents will be 65 years old or older, according to the US Census Bureau. This demographic shift causes an increased incidence of diseases such as atherosclerosis, which directly correlates with higher stent utilization rates for cardiovascular interventions.
Organizations like the National Institutes of Health report that older adults are more likely to experience vascular complications necessitating surgical procedures. The implications of this aging demographic present expansive growth prospects for companies focused on surgical stents, including major players like Abbott Laboratories and Boston Scientific.
The US Surgical Stents Market, categorized by Type, showcases a diverse range of stenting solutions that cater to various medical needs. The market encompasses key segments including Cardiac Stents, Urinary Stents, Biliary Stents, Esophageal Stents, Prostatic Stents, and other specialized stents. In the medical field, the application of stents has proven vital in enhancing patient outcomes, particularly in cardiovascular interventions where Cardiac Stents play a crucial role in preventing artery blockages.
This segment is pivotal due to the prevalence of coronary artery diseases in the US, driving demand for effective interventions that support patients in maintaining healthier lives. Urinary Stents have similarly gained significant traction, addressing conditions such as urinary obstruction and complications related to kidney stones. These devices are critical in ensuring the unobstructed flow of urine, thus preventing potential kidney damage and other adverse effects associated with obstruction.
The necessity for timely and effective management in this area creates opportunities for innovation and improvement within the market. Biliary Stents are also crucial, particularly for patients facing bile duct obstructions often due to malignant conditions. Their role in facilitating bile drainage dramatically impacts treatment plans and patient quality of life, which contributes to their growing importance recognized within the healthcare framework.
Meanwhile, the urgency for Esophageal Stents has risen, especially as they address strictures resulting from various conditions, including cancer. These stents enable patients to maintain essential nutritional intake and improve overall quality of life, making them a critical addition to therapeutic measures. Prostatic Stents, though a smaller market segment, cater to male patients suffering from benign prostatic hyperplasia (BPH) and have become increasingly popular due to the rising geriatric population in the US.
As the aging demographic grows, the demand for such interventions is anticipated to increase, reflecting the need for effective management strategies in urologic health. Other stents present in the market might encompass various specialties and emerging technologies that are continuously evolving to meet specific patient and procedural demands. With advancements in materials and technology, the US Surgical Stents Market reflects a strong trend toward minimally invasive procedures, which resonate with the increasing patient preference for such options.
Growth drivers include a growing geriatric population and advancements in stent technologies that elevate effectiveness and reduce complications. However, market challenges such as regulatory hurdles, varying reimbursement policies, and competition from alternative treatments need to be navigated to leverage opportunities for expansion. This intricate segmentation highlights the multifaceted nature of the US Surgical Stents Market, necessitating a comprehensive understanding to cater to the needs of diverse patient populations effectively. Overall, the demand is poised for substantial growth, underscoring the essential nature of these medical devices in contemporary healthcare.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Surgical Stents Market is experiencing significant growth, driven by advancements in healthcare technologies and increasing prevalence of chronic diseases. Within the Type of Materials segment, various materials such as metal, standard polymer, and biodegradable polymer are utilized, each playing a vital role. Metal stents are often favored for their strength and durability, providing essential support in critical procedures.
Conversely, standard polymer stents offer flexibility and ease of insertion, contributing to patient comfort during treatment. Biodegradable polymer stents are emerging as a transformative option, gradually dissolving within the body and minimizing long-term complications. This material variety not only ensures that healthcare providers can select the most suitable stent for individual patient needs but also enhances the overall effectiveness of surgical interventions.
The US clinical guidelines increasingly support the integration of these materials, promoting innovations that align with the growing trend towards personalized medicine. As the US population ages and the incidence of cardiovascular diseases rises, the demand for diverse surgical stents increases, indicating robust market potential for future growth.
The Application segment of the US Surgical Stents Market is characterized by its diverse focus on various health conditions requiring stenting, particularly in Cardiac Diseases and Urinary Tract Diseases. Cardiac stenting remains critical due to the rising prevalence of cardiovascular diseases in the US, driven by factors such as an aging population and increased incidences of lifestyle-related conditions. This sector continues to innovate with advanced technologies and materials, enhancing patient outcomes and recovery times.
Urinary Tract Diseases also represent a significant portion of the market, where stents are essential for managing obstructions and aiding the healing process after procedures. The importance of urinary stenting is amplified by the growing awareness and diagnosis of kidney-related ailments in the US. Other applications encompass a wide variety of specialty uses, contributing to the overall market growth and providing opportunities for advancements in minimally invasive techniques.
The US Surgical Stents Market statistics reflect robust investment and research driving these segments, as healthcare providers seek effective solutions tailored to patient needs across these critical applications.
The US Surgical Stents Market is predominantly influenced by its End User segment, which includes Hospital and Clinics, representing critical components in healthcare delivery. Hospitals play a vital role due to their capacity to perform complex surgical procedures and provide advanced care, thereby driving the demand for various types of surgical stents. Clinics, on the other hand, offer a more accessible healthcare option for patients requiring minor procedures and follow-ups, capturing a significant share of the market.
Their ability to cater to outpatient services effectively supports the overall utilization of stents. Factors such as the rising prevalence of chronic diseases, including cardiovascular and urological conditions, are contributing to increased surgical interventions across these facilities. Moreover, advancements in medical technology are enhancing the efficiency and effectiveness of stent procedures while leading to improved patient outcomes.
The growth in patient awareness regarding minimally invasive surgeries is further bolstering the demand in both Hospitals and Clinics, creating ample opportunities for market players. With a focus on patient-centered care, these settings continue to adapt and expand their surgical capabilities, significantly impacting the US Surgical Stents Market dynamics.
The US Surgical Stents Market is characterized by a dynamic and competitive environment that reflects the ongoing advancements in medical technology and a growing demand for minimally invasive surgical procedures. With a variety of stents designed for different applications, including vascular, urological, and gastrointestinal uses, the market has attracted numerous key players who strive to innovate and improve patient outcomes.
Companies are focusing on enhancing the biocompatibility and functionality of stents, while also addressing the cost-effectiveness and accessibility of these medical devices. The competitive landscape is shaped by various factors such as product development, market strategies, partnerships, and mergers, which contribute to a rapidly evolving marketplace that actively seeks to meet the diverse needs of healthcare providers and patients alike.
Halyard Health has established a notable presence in the US Surgical Stents Market, leveraging its expertise in medical devices and commitment to quality and innovation. The company is recognized for its strategic focus on the development of advanced stenting solutions that cater specifically to the surgical needs of healthcare professionals. Halyard Health's strengths lie in its extensive product portfolio, which enhances surgical procedures and provides reliable options across various specialties.
The brand's reputation for high standards of manufacturing and robust logistics has enabled it to foster strong relationships with healthcare providers, ensuring that its stents are readily available when needed. In addition, Halyard Health consistently invests in research and development to maintain its competitive edge and respond adeptly to evolving market demands. Teleflex has also made significant strides in the US Surgical Stents Market through its diverse range of medical devices focused primarily on improving patient care and surgical efficiency.
The company offers several key products within the stent category, targeting areas such as vascular surgery and urology, which are crucial to the overall health system. Teleflex's market presence is underpinned by its strategic approach to mergers and acquisitions that expand its product reach and enhance its capabilities in stent manufacturing. By integrating innovative technologies and maintaining a portfolio of established brands, Teleflex creates a synergistic effect that not only strengthens its position in the market but also improves the quality and performance of its stenting solutions.
The company's ongoing commitment to excellence, combined with its ability to adapt to the changing healthcare landscape, positions it as a formidable player in the US Surgical Stents Market.
Recent developments in the US Surgical Stents Market have shown significant activity, with companies like Boston Scientific and Medtronic launching new devices aimed at improving patient outcomes. Notably, Abbott has been focusing on innovations that cater to the cardiovascular sector, enhancing its presence in the market. In terms of mergers and acquisitions, Halyard Health recently announced strategic collaborations to enhance its product offerings, while Teleflex has made moves to acquire specific technologies that bolster its minimally invasive solutions.
Furthermore, in June 2022, Stryker completed its acquisition of Mako Surgical, expanding its capabilities in robotic-assisted surgery, which indirectly impacts the stent market. The US Surgical Stents Market valuation is witnessing growth driven by rising cardiovascular diseases and increased demand for minimally invasive procedures, with organizations advocating for better healthcare measures. Major companies including Johnson and Johnson, AngioDynamics, and Cook Medical are responding to these trends by investing in Research and Development to introduce advanced stent technologies.
Market dynamics in the past couple of years, particularly in 2020 and 2021, have intensified competition, as firms strive to maintain leadership amidst evolving healthcare needs and technological advancements.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 2.83(USD Billion) |
| MARKET SIZE 2024 | 3.5(USD Billion) |
| MARKET SIZE 2035 | 8.5(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.401% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Halyard Health, Teleflex, AngioDynamics, Smith and Nephew, Johnson and Johnson, Abbott, Stryker, B. Braun Melsungen, Cook Medical, Cardinal Health, Terumo, Boston Scientific, Medtronic, W. L. Gore and Associates |
| SEGMENTS COVERED | Type, Type Of Materials, Application, End User |
| KEY MARKET OPPORTUNITIES | Increasing geriatric population, Advancements in stent technology, Rising prevalence of cardiovascular diseases, Growing demand for minimally invasive procedures, Expanding applications in various surgeries |
| KEY MARKET DYNAMICS | technological advancements, increasing prevalence of cardiovascular diseases, rising geriatric population, regulatory compliance challenges, growing demand for minimally invasive procedures |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Surgical Stents Market is expected to be valued at 3.5 billion USD in 2024.
By 2035, the US Surgical Stents Market is anticipated to reach a value of 8.5 billion USD.
The market is expected to grow at a CAGR of 8.401 percent during the forecast period from 2025 to 2035.
Cardiac stents are expected to hold the largest market share, valued at 1.089 billion USD in 2024.
The projected value of urinary stents in the market is estimated to be 1.986 billion USD by 2035.
Major players in the market include Halyard Health, Teleflex, AngioDynamics, Smith and Nephew, and Johnson and Johnson among others.
The anticipated market value for biliary stents is 0.544 billion USD in 2024.
Esophageal stents are projected to grow at a significant pace, reaching an estimated value of 1.192 billion USD by 2035.
Key growth drivers include increasing prevalence of chronic diseases and advancements in stent technology.
The competitive landscape features several prominent companies vying for market share, indicating a dynamic and evolving market environment.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
